Celon Pharma S.A. (8RP)
FSX
5.00
+0.01 (+0.30%)
Real-time Data
06:00 AM
Day's Range
5.005.00
52 wk Range
4.265.77
Financial Statements - 8RP - Celon Pharma S.A.
Revenue
176.61M▲ 7.4%
Net Income
-79.36M▼ 130.4%
EBITDA
-24.86M▼ 408.0%
Free Cash Flow
23.85M▲ 169.9%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|---|---|
| Sales | - | 176.61M | 164.39M | 161.91M | 169.55M | 135.48M |
| Cost of Goods | - | 63.17M | 66.81M | 66.46M | 61.71M | 36.64M |
| Gross Profit | - | 113.44M | 97.57M | 95.45M | 107.84M | 98.83M |
 Operating Expense | - | - | - | - | - | - |
| Operating Income | -24.86M | -39.97M | -30.99M | -38M | -13.60M | -6.73M |
| Non-Operating Interest | - | - | - | - | - | - |
| Other Income Expense | - | - | - | - | - | - |
| Pre Tax Income | - | -39.36M | -19.96M | -36.44M | -15.08M | -5.58M |
| Income Tax | - | -4.92M | 8.15M | 2.83M | -3.48M | -4.67M |
| Net Income | -79.36M | -34.44M | -28.12M | -39.27M | -11.60M | -917K |
| EPS Basic | -1.49 | -0.64 | -0.55 | -0.77 | -0.25 | -0.02 |
| EPS Diluted | -1.49 | -0.65 | -0.55 | -0.77 | -0.25 | -0.02 |
| Basic Shares Outstanding | 53.26M | 52.51M | 51.05M | 212.31M | 194.22M | 187.24M |
| Diluted Shares Outstanding | 53.26M | 52.51M | 51.05M | 212.31M | 194.22M | 187.24M |
| Ebit | -24.86M | -36.89M | -17.30M | -34.77M | -13.53M | -4.92M |
| Ebitda | -24.86M | 8.07M | 22.63M | 7.39M | 27.67M | 29.19M |
| Net Income Continuous Operations | - | -39.36M | -19.96M | -36.44M | -15.08M | -5.58M |
| Minority Interests | - | - | - | - | - | - |
| Preferred Stock Dividends | 0 | 0 | 0 | 0 | 0 | 0 |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
